Repositioning Lidocaine as an Anticancer Drug: The Role Beyond Anesthesia
While cancer treatment has improved dramatically, it has also encountered many critical challenges, such as disease recurrence, metastasis, and drug resistance, making new drugs with novel mechanisms an urgent clinical need. The term “drug repositioning,” also known as old drugs for new uses, has em...
Main Authors: | Daipeng Zhou, Lei Wang, Qingbin Cui, Ryma Iftikhar, Yanfei Xia, Peng Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-07-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2020.00565/full |
Similar Items
-
Combination of levofloxacin and cisplatin enhances anticancer efficacy via co-regulation of eight cancer-associated genes
by: Xiaoqiong He, et al.
Published: (2022-08-01) -
Comparison of Lidocaine-Nitroglycerine with Lidocaine for Intravenous Regional Anesthesia
by: Nadia Banihashem, et al.
Published: (2012-01-01) -
Can Some Anticancer Drugs Be Repurposed to Treat Amyotrophic Lateral Sclerosis? A Brief Narrative Review
by: Rosa Luisa Potenza, et al.
Published: (2024-02-01) -
Determination and Comparison of the Onset Time of Epidural Anesthesia with Lidocaine-Sufentanil and Lidocaine-Bicarbonate
by: Mahmoud Reza Ale- Bouye, et al.
Published: (2000-09-01) -
"Lidocaine anaphylaxis after epidural anesthesia for cesarean section "
by: Setayesh AR
Published: (2001-07-01)